Cornerstone Therapeutics

Cornerstone Therapeutics

Pharmaceutical company focused on developing and commercializing products for the respiratory system.
  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO

$30.0m

Debt

N/A

Acquisition
Total Funding-

Recent News about Cornerstone Therapeutics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Cornerstone Therapeutics

Edit
EKR Therapeutics
ACQUISITION by Cornerstone Therapeutics May 2012
Cardiokine
ACQUISITION by Cornerstone Therapeutics Jan 2012
Critical Therapeutics.
ACQUISITION by Cornerstone Therapeutics May 2008